Dr. Christopher Kellner · NYC Neurosurgeon retweetledi

.@route92med has today announced the first enrolment in SUMMIT RISE—a 500-patient, real-world, post-clearance study evaluating the performance of the company’s portfolio of #neurovascular interventional solutions
@SunilAShethMD @rwregen @chriskellnerMD
neuronewsinternational.com/route-92-begin…
English





























